Skip to main content

Stephen Uden, M.D.

Stephen Uden, M.D.

Co-Founder, Rallybio
Image
Stephen Uden headshot

Steve Uden is the Co-Founder of Rallybio. Earlier he led Alexion Research.  Alexion Research focussed on the discovery of novel therapies that have a transformative impact on patients with devastating and rare disease.

Prior to joining Alexion, Steve was the Head of Oncology Development for Novartis Pharma in Japan.. There he participated in a series of global programs that led to four oncology drug approvals in Japan during his time there.  Previously, Steve served as VP and Head of R&D for Wyeth Japan – administering a full spectrum of R&D activities and strategies in Asia Pacific across all of Wyeth’s therapeutic areas. Earlier in his career, Steve held leadership roles in several biopharmaceutical companies, including Head of R&D at Neurogen Corp., where he oversaw target selection through clinical development, and supported new business strategy.

Steve earned his Bachelor of Medicine and Bachelor of Science from St. Thomas Medical School, University of London, as well as membership in the Royal College of Physicians and Faculty of Pharmaceutical Medicine.